Page last updated: 2024-08-21

evans blue and tacrolimus

evans blue has been researched along with tacrolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Furuichi, Y; Maeda, M; Matsuoka, N; Mutoh, S; Noto, T; Yoneda, Y1

Other Studies

2 other study(ies) available for evans blue and tacrolimus

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
    Brain research, 2009, Feb-13, Volume: 1254

    Topics: Animals; Blood-Brain Barrier; Brain; Endothelial Cells; Evans Blue; Immunohistochemistry; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Microvessels; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Inbred SHR; Recombinant Proteins; Tacrolimus; Tissue Plasminogen Activator

2009